February 15, 2016

New Technology Equals Additional Reimbursement

By

Today, February 16, the Centers for Medicare & Medicaid Services (CMS) is holding a New Technology Town Hall Meeting at the CMS Headquarters in Baltimore.

The New Technology meeting is being held to allow the agency to review applications for New Technology designation in the Medicare Severity-Diagnosis Related Groups (MS-DRGs) reimbursement methodology for the Inpatient Prospective Payment System (IPPS). This designation is important for hospitals as it means the potential for additional reimbursement. During the 2016 fiscal year, the additional reimbursement ranged from $1,000 to $72,000 per case.

New technology add-on payments were created to ensure that hospitals were adequately compensated for new devices and/or procedures. The criteria for new technology includes requirements that the medical service or technology be new (within 2-3 years), that it demonstrates significant clinical improvement, that it has gained approval by the Federal Drug Administration (FDA), and that it can be identified by CPT, HCPCS, National Drug Code, or ICD-10-PCS (formerly ICD-9-CM Volume 3) codes.

The Town Hall meeting will focus on the 2016 New Technology designations and determine if they should continue. These 2016 technologies included:

  1. Argus II Retinal Prosthesis System: a device used to treat retinitis pigmentosa that had a potential additional reimbursement of $72,028.75.
  2. Cardio-MEMS HF Monitoring System: a device used to treat heart failure that had a potential additional reimbursement of $8,875.
  3. MitraClip: a device used to treat mitral valve regurgitation that had a potential additional reimbursement of $15,000.
  4. Responsive Neurostimulator (RNS) System: a device used to treat epilepsy that had a potential additional reimbursement of $18, 475.
  5. BLINCYTO (Blinatumomab): a substance used to treat acute lymphoblastic leukemia that had potential additional reimbursement of $27.017.15 based on a 17-day treatment cycle.
  6. Lutonix Drug Coated Balloon (DCB) for PTA: a device used to treat peripheral artery disease that had a potential additional reimbursement of $1,035.72.

BLINCYTO and the Lutonix Drug Coated Balloon were new in 2016. The first four items are in danger of being discontinued for 2017. A new technology/service cannot maintain the designation for longer than three years. The IPPS Final Rule for 2017 will contain the final determinations, but we will get a glimpse of the decisions sometime in April or May.

Laurie Johnson, MS, RHIA, CPC-H, FAHIMA, AHIMA-Approved ICD-10-CM/PCS Trainer

Laurie M. Johnson, MS, RHIA, FAHIMA is currently a senior healthcare consultant for Revenue Cycle Solutions based in Pittsburgh, Pa. Laurie is an AHIMA approved ICD-10-CM/PCS Trainer. She has more than 35 years of experience in health information management and specializes in coding and related functions. She has been a featured speaker in over 40 conferences and will be speaking at 2017 AHIMA Coding Community Meeting in Los Angeles, Ca. Laurie has been a frequent guest on Talk Ten Tuesdays.

Related Stories

  • ICD-11 is Coming – Take Time to Adjust
    The new classification is designed as a database and has up to 13 dimensions. The World Health Organization (WHO) will be releasing the 11th Revision to the International Classification of Diseases, or ICD-11, this May. The WHO and many of…
  • Outpatient CDI Programs Grow as Hospitals Move to Value-based Care
    There is a definite need for outpatient CDI programs – provided that hospital administration takes the right approach to its development and implementation. Interest in outpatient clinical documentation integrity (CDI) programs is multiplying as more and more hospital services are…
  • “Assumptive” Coding for Heart Disease – A Coder’s Perspective
    Official guidance on ICD-10-CM coding raises questions regarding how to document cardiac care. The first step in choosing the proper ICD-10-CM code is reading the medical documentation to identify the diagnosis the provider has documented and confirmed. If there is…